How should I manage continued menstrual bleeding after switching from Feirza (combined oral contraceptive) to Provera (medroxyprogesterone acetate), given that the bleeding stopped by week 2 on Feirza, restarted in week 3, and persists 24 hours after the first dose of Provera?

Continue Provera and Expect Bleeding to Stop Within 3-5 Days

You should continue taking Provera (medroxyprogesterone acetate) as prescribed, as bleeding typically stops within 3-5 days of initiating therapy for abnormal uterine bleeding, and 24 hours is too early to assess treatment failure. 1

Why Bleeding Persists After Only 24 Hours

The continued bleeding after just one dose of Provera is expected and does not indicate treatment failure. According to the FDA label, Provera is prescribed at 5-10 mg daily for 5-10 days for abnormal uterine bleeding 1. The mechanism requires time to stabilize the endometrium—you cannot judge efficacy after a single dose.

Research demonstrates that when medroxyprogesterone acetate is used for acute uterine bleeding, the median time to bleeding cessation is 3 days, with 76% of patients achieving cessation by day 14 2. In adolescents with severe bleeding, high-dose medroxyprogesterone stopped bleeding in only 25% within 24 hours, with most requiring 2-4 days 3.

The Clinical Algorithm

Days 1-3 of Provera:

• Continue medication as prescribed (typically 5-10 mg daily)
• Expect ongoing bleeding—this is normal
• No intervention needed unless bleeding is hemodynamically significant

Days 4-7:

• Most patients experience bleeding cessation by this point 2, 3
• If bleeding continues but is decreasing in volume, continue Provera through the full 5-10 day course

After completing the full course:

• If bleeding persists or worsens, consider adding NSAIDs (ibuprofen or mefenamic acid) for 5-7 days during bleeding episodes 4, 5
• Alternative: Add short-term estrogen therapy (low-dose combined oral contraceptives or estrogen alone) for 10-20 days 4, 5

Why Feirza (Combined Oral Contraceptive) Failed

The breakthrough bleeding on week 3 of Feirza suggests inadequate endometrial suppression with that particular formulation. Unscheduled bleeding is common during the first 3-6 months of combined hormonal contraceptive use and generally decreases with continued use 6. However, switching to progestin-only therapy (Provera) after only 3 weeks doesn't allow sufficient time to assess whether the bleeding would have resolved with continued use.

Critical Pitfalls to Avoid

1. Don't abandon Provera prematurely: The single biggest mistake is discontinuing therapy before completing at least 5 days, as the endometrium requires time to stabilize 1

2. Rule out pregnancy: Before continuing any hormonal therapy, ensure pregnancy has been excluded, as Provera should not be used in pregnancy 1

3. Assess for underlying pathology: If clinically indicated, consider structural causes (polyps, fibroids), coagulopathy, thyroid disorders, or sexually transmitted infections 7, 4. However, if these were already evaluated when starting Feirza, repeat evaluation is unnecessary at 24 hours.

4. Don't expect immediate results: Unlike combined hormonal contraceptives that contain estrogen (which can stop bleeding more rapidly), progestin-only therapy works by inducing endometrial atrophy and decidualization, which takes several days 8

If Bleeding Continues Beyond 7-10 Days

Should bleeding persist after completing the full Provera course, evidence supports these interventions in order of preference:

1. NSAIDs during bleeding episodes (mefenamic acid or ibuprofen, 5-7 days) 4, 9, 5
2. Add estrogen therapy: Either low-dose combined oral contraceptives or estrogen alone for 10-20 days 4, 9, 5
3. Consider tranexamic acid (5 days during bleeding) 4, 5

Long-Term Contraceptive Planning

Once the acute bleeding episode resolves, discuss long-term contraceptive options. If hormonal contraception is desired:

• Levonorgestrel IUD shows the highest efficacy for reducing menstrual blood loss (93% reduction at 6 months) 10
• Extended or continuous combined hormonal contraceptives may prevent recurrent bleeding episodes, though breakthrough bleeding is common in the first 3-6 months 6
• Injectable DMPA (depot medroxyprogesterone acetate) often leads to amenorrhea but may cause irregular bleeding initially 6, 10

The key message: Give Provera at least 3-5 days before considering it ineffective. Bleeding at 24 hours is expected and does not warrant changing therapy.